Observational studies, clinical trials, and the women’s health initiative
- 112 Downloads
The complementary roles fulfilled by observational studies and randomized controlled trials in the population science research agenda is illustrated using results from the Women’s Health Initiative (WHI). Comparative and joint analyses of clinical trial and observational study data can enhance observational study design and analysis choices, and can augment randomized trial implications. These concepts are described in the context of findings from the WHI randomized trials of postmenopausal hormone therapy and of a low-fat dietary pattern, especially in relation to coronary heart disease, stroke, and breast cancer. The role of biomarkers of exposure and outcome, including high-dimensional genomic and proteomic biomarkers, in the elucidation of disease associations, will also be discussed in these same contexts.
KeywordsBiomarker Cohort study Diet Genomics Hormones Proteomics Randomized controlled trial
Unable to display preview. Download preview PDF.
- Breslow NE, Day NE (1980) Statistical methods in cancer research—the analysis of case-control studies, vol 1. IARC Scientific Publications 32, International Agency for Research on Cancer, Lyon, FranceGoogle Scholar
- Breslow NE, Day NE (1987) Statistical methods in cancer research—the design and analysis of cohort studies, vol 2. IARC Scientific Publications 32, International Agency for Research on Cancer, Lyon, FranceGoogle Scholar
- Freedman LS, Potischman N, Kipnis V, Midthune D, Schatzkin A, Thompson FE, Troiano RP, Prentice R, Patterson R, Carroll R and Subar AF (2006). A comparison of two dietary instruments for evaluating the fat-breast cancer relationship. Int. J. Epidemiol. 35(4): 1011–1021, [Epub May 3, 2006]CrossRefGoogle Scholar
- Heitmann BL and Lissner L (1995). Dietary underreporting by obese individuals—is it specific or non-specific? Br Med J 311: 986–989 Google Scholar
- Prentice RL, Caan B, Chlebowski R, Patterson R, Kuller LH, Ockene JK, Margolis KL, Limacher MC, Manson JE and Parker LM et al (2006). Low-fat dietary pattern and risk of invasive breast cancer: the Women’s Health Initiative randomized controlled dietary modification trial. J Am Med Assoc 295: 629–642 CrossRefGoogle Scholar
- Prentice RL, Langer R, Stefanick ML, Howard BV, Pettinger M, Anderson G, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M and Wactawski-Wende J (2005). Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women’s Health Initiative clinical trial. Am J Epidemiol 162: 1–11 CrossRefGoogle Scholar
- Prentice RL, Langer RD, Stefanick ML, Howard BV, Pettinger M, Anderson GL, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M and Wactawski-Wende J (2006). Combined analysis of Women’s Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease. Am J Epidemiol 163(7): 589–599 CrossRefGoogle Scholar
- Prentice RL and Sheppard L (1990). Feasibility and importance of clinical trials of a low fat diet to reduce cancer risk. Prog Clin Biol Res 346: 205–215 Google Scholar
- Shaw P (2006) Estimation methods for Cox regression with nonclassical measurement error. Doctoral Dissertation Department of Biostatistics, University of WashingtonGoogle Scholar
- Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, M. J. O’Sullivan, Margolis KL, Ockene JK, Phillips L and Pottern L et al (2006). Calcium, vitamin D supplementation and colorectal cancer in postmenopausal women: the Women’s Health Initiative clinical trial. N Eng J Med 354: 684–696 CrossRefGoogle Scholar
- Wang H, Clouthier SG, Galchev V, Misek DE, Duffner U, Min CK, Zhao R, Tra J, Omenn GS, Ferrara JL and Hanash SM (2005). Intact-protein-based high-resolution three-dimensional quantitative analysis system for proteome profiling of biological fluids. Mol and Cell Proteomics 4: 618–625 CrossRefGoogle Scholar